Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Current Trends in Endocrinology   Volumes    Volume 6 
Control of postprandial hyperglycemia: How important is it in the prevention of diabetic complications
Anil K. Mandal, Linda M. Hiebert
Pages: 53 - 63
Number of pages: 11
Current Trends in Endocrinology
Volume 6 

Copyright © 2012 Research Trends. All rights reserved

Fasting blood glucose (FBG) >126 mg/dL (7 mmol/L) and/or glycosylated hemoglobin (HbA1c) >6.5% have traditionally been used as a marker for the diagnosis of diabetes and initiation of a treatment plan. Despite the use of these diagnostic markers and a plethora of oral hypoglycemic agents, diabetic complications namely, cardiovascular disorders, renal failure and dialysis, and amputations, are on the rise.  Therefore a reasonable concern is that either the definition of diabetes or the prevalent therapy with oral hypoglycemic agents, or both, are faulty. Abundant literature is available regarding the importance of using 2-hour postprandial glucose (2hPPG) in glycemic control for the prevention of diabetic complications. A robust association has been shown between 1-h or 2-h postprandial hyperglycemia (>200 mg/dL; 11.1 mmol/L) and cardiovascular disorders and mortality. Notwithstanding the availability of such important information, 2hPPG control is still under-used in clinical practice of diabetes care. Worse than that, popularity of use of FBG and/or HbA1c as a guide for diabetes care has permitted an incorrect diagnosis of Type 2 diabetes in numerous hypertensive patients treated with a thiazide diuretic and having elevated glucose levels followed by mistreatment with oral hypoglycemic agents. The result is subsequent development of overt diabetes in many individuals, some of them are riddled with numerous complications such as foot ulcer, gangrene, kidney failure or heart disease. This article is dedicated to redirecting the attention from using FBG and or HbA1c to 2hPPG as a fundamental tool for evaluation of diabetes and to focus on therapy encompassing 2hPPG.  Evidence has emerged from basic as well as clinical research claiming the importance of control of postprandial hyperglycemia in the prevention of diabetic complications. Prevention of diabetic complications is attainable by control of postprandial hyperglycemia with the prescription of a combination of Glargine insulin twice daily (12 hours apart) and treatment of glycemic excursions with fast-acting insulin.
View Full Article  


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms